- Lung cancer remains the leading cause of cancer-related deaths worldwide, with more than 2.2 million people diagnosed globally last year.1
- The VENTANA PD-L1 (SP263) Assay helps determine which non-small cell lung cancer patients may benefit from treatment with Tecentriq immunotherapy based on the results of the Phase III IMpower010 study.
- This new test expands Roche’s industry leading portfolio of companion diagnostics and builds on our commitment to improve personalized healthcare for better patient outcomes.
Bayer moment blazoned uninterrupted progress in delivering client- concentrated, sustainable agrarian invention in an update with investors. The company’s success in rephrasing exploration and development ( R&D) leadership into discerned and advanced products for growers is driving functional performance, while shaping the future of husbandry. Progress is being powered by strong marketable prosecution in a positive request terrain, particularly in pesticides and dressings.
“ As the leader in agrarian input deals, profitability and R&D investment, we’ve delivered on marketable mileposts that will advance our leadership, further adding confidence in our capability to achieve our pretensions,” said Liam Condon, member of the Board of Management of Bayer AG and President of the Crop Science Division. “ Our commanding marketable portfolio, digital platform and unmatched invention are driving significant value for our farmer guests. We’re confident that the confluence of our technology platforms to drive further client-centric results will deliver above request deals growth and leading profitability as we look out to 2024.”
Innovation leadership fueling strong request position
Bayer is farther strengthening its request position through lately capitalized inventions. For illustration, in the crucial North American request, Bayer has defended its position as the number one soybean weed control system provider with its Roundup Ready Xtend ® Crop System.
Bayer is successfully upgrading its Roundup Ready 2 Xtend ® footmark with XtendFlex ® soybeans, which have formerly reached roughly 15 million acres this time. This rearmost immolation adds glufosinate forbearance to give fresh weed- control inflexibility. Farmers chose to plant these two particularity immolations on further than 55 of theU.S. soybean acres this time. Bayer expects to continue to upgrade soybean acres to XtendFlex ® in theU.S. in the times ahead, thanks to the proven yield benefits and exceptional weed control. In Brazil, the launch of its new Intacta 2 Xtend ® soy on roughly acres is presently underway, as the company upgrades its leading soybean particularity platform in South America. Erected on the performance of first- generation Intacta, Intacta 2 Xtend ® adds two proteins for nonentity control, which is important for nonentity resistance operation, as well as forbearance to dicamba.
Bayer is supplementing this continued deals instigation in Brazil with pesticides by upgrading its Fox Franchise with Fox ® Xpro Fungicide. To date, Fox ® Xpro has been a crucial motorist of its global deals in pesticides, which rose 22 on a currency-and portfolio- acclimated base in the first half of the financial time. With 25 request share in soybean pesticides in Brazil, Bayer plans to upgrade this product in 2022 with the launch of Fox Supra, further expanding its commanding position in this largely important request, with a peak deals eventuality of further than€ 500 million.
In sludge, the company is introducing its sludge rootworm 3 (CRW3) technology as part of SmartStax ® PRO, and the deals rollout for the 2022 launch in theU.S. is underway. This time’s field trials brought to light the upgraded product’s better daises and stronger roots. In fact, mongrels with the SmartStax ® PRO technology demonstrated a 97- palm rate in the field.
“ This is a particularly timely preface and we anticipate it to be well- entered by farmers following increased rootworm pressure this summer in theU.S.,” added Condon. “ Not only did SmartStax and SmartStax ® PRO perform well, but we were particularly pleased with how these products performed compared to competitive druthers.”
The company anticipates transitioning its 15-million-acre particularity SmartStax footmark in theU.S. over the coming many times to this new CRW3 technology. Inventions like this cover sludge yield, which is made possible by top- performing germplasm. This helps sustain the company’s leading request positions in the top sludge requests around the world.
Leading the digital metamorphosis of husbandry and setting new norms in sustainability
Bayer is also expanding its assiduity- leading Climate FieldView ™ digital husbandry platform – now being used on further than 180 million subscribed acres across 23 countries. The company is also seeing increased deals of its own products among FieldView ™ druggies.
The connectivity from these acres, including logging information from agronomists, sprayers and combines, is helping growers make data- driven opinions and optimize yield while lowering the environmental footmark of their husbandry operations.
FieldView ™ is also anticipated to enable a simple, robust, scalable process to measure, corroborate and report on practices that sequester carbon. In the first time of its Carbon Initiative, Bayer enrolled further than FieldView ™ druggies in carbon husbandry trials in theU.S. and Brazil alone.
“ With carbon requests worth further than$ 200 billion annually, we’re leading the way in helping make carbon tilling a reality through our global Carbon Initiative,” added Condon. “ By incentivizing growers to borrow climate smart practices, as well as unborn products that yield further and sequester further carbon, we’re creating new value openings for the planter and our company.”
Bayer is a global enterprise with core capabilities in the life wisdom fields of health care and nutrition. Its products and services are designed to help people and earth thrive by supporting sweats to master the major challenges presented by a growing and growing global population. Bayer is committed to drive sustainable development and induce a positive impact with its businesses. At the same time, the Group aims to increase its earning power and produce value through invention and growth. The Bayer brand stands for trust, trustability and quality throughout the world. In financial 2020, the Group employed around people and had deals of41.4 billion euros. R&D charges before special particulars amounted to4.9 billion euros.
Source link: https://media.bayer.com/